Science Editors
Sort by
2 items
-
MarketWatch - Business
Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims
Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged the pharma company and two ...5 hours ago -
The Wall Street Journal - Tech
Science Editors Raise New Doubts on Meta's Claims It Isn't Polarizing
The editorial warns that Facebookâs changes after the 2020 election may have swayed the conclusions of a prominent study.7 hours ago